Anti-ANGP4/ ANGPT4/ ANG3 functional antibody

Anti-ANGP4/ ANGPT4/ ANG3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to ANGPT4/ANGPT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0666-Ab-1/ GM-Tg-hg-SE0666-Ab-2Anti-Human ANGPT4 monoclonal antibodyHuman
GM-Tg-rg-SE0666-Ab-1/ GM-Tg-rg-SE0666-Ab-2Anti-Rat ANGPT4 monoclonal antibodyRat
GM-Tg-mg-SE0666-Ab-1/ GM-Tg-mg-SE0666-Ab-2Anti-Mouse ANGPT4 monoclonal antibodyMouse
GM-Tg-cynog-SE0666-Ab-1/ GM-Tg-cynog-SE0666-Ab-2Anti-Cynomolgus/ Rhesus macaque ANGPT4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0666-Ab-1/ GM-Tg-felg-SE0666-Ab-2Anti-Feline ANGPT4 monoclonal antibodyFeline
GM-Tg-cang-SE0666-Ab-1/ GM-Tg-cang-SE0666-Ab-2Anti-Canine ANGPT4 monoclonal antibodyCanine
GM-Tg-bovg-SE0666-Ab-1/ GM-Tg-bovg-SE0666-Ab-2Anti-Bovine ANGPT4 monoclonal antibodyBovine
GM-Tg-equg-SE0666-Ab-1/ GM-Tg-equg-SE0666-Ab-2Anti-Equine ANGPT4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0666-Ab-1/ GM-Tg-hg-SE0666-Ab-2; GM-Tg-rg-SE0666-Ab-1/ GM-Tg-rg-SE0666-Ab-2;
GM-Tg-mg-SE0666-Ab-1/ GM-Tg-mg-SE0666-Ab-2; GM-Tg-cynog-SE0666-Ab-1/ GM-Tg-cynog-SE0666-Ab-2;
GM-Tg-felg-SE0666-Ab-1/ GM-Tg-felg-SE0666-Ab-2; GM-Tg-cang-SE0666-Ab-1/ GM-Tg-cang-SE0666-Ab-2;
GM-Tg-bovg-SE0666-Ab-1/ GM-Tg-bovg-SE0666-Ab-2; GM-Tg-equg-SE0666-Ab-1/ GM-Tg-equg-SE0666-Ab-2
Products NameAnti-ANGPT4 monoclonal antibody
Formatmab
Target NameANGPT4
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANGPT4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0666-Ag-1Recombinant multi-species ANGP4/ ANGPT4/ ANG3 protein


    Target information

    Target IDGM-SE0666
    Target NameANGPT4
    Gene ID51378,11602,296269,715213,609626,101091274,617915,100067818
    Gene Symbol and SynonymsAgpt4,ANG-3,ANG-4,ANG3,ANG4,ANGPT4,ANGPTL4
    Uniprot AccessionQ9Y264,Q24K15
    Uniprot Entry NameANGP4_HUMAN,ANGP4_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000101280
    Target ClassificationN/A

    The target: ANGPT4, gene name: ANGPT4, also named as ANG3, ANG4. Angiopoietins are proteins with important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The mechanism by which they contribute to angiogenesis is thought to involve regulation of endothelial cell interactions with supporting perivascular cells. The protein encoded by this gene functions as an agonist and is an angiopoietin. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.